Get started
Author

Subir Ray

Observed names: Ray Subir, Ray, Subir, S. Ray
ORCID: 0000-0002-2362-1139
Observed ORCID: 0000-0002-2362-1139
OpenAlex ID: A5042085196
Pros and cons for use of statins in people with coronavirus disease-19 (COVID-19)
2020 · Ray Subir, Mukherjee Jagat J, et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 72
PDF
Observational Study of Effects of Saroglitazar on Glycaemic and Lipid Parameters on Indian Patients with Type 2 Diabetes
2015 · Sanjay Chatterjee, Anirban Majumder, et al. · Scientific Reports · 45
PDF
Use of pioglitazone in people with type 2 diabetes mellitus with coronavirus disease 2019 (COVID-19): Boon or bane?
2020 · Mukherjee Jagat J, Gangopadhyay Kalyan K, et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 27
PDF
Assessing prevalence and predictors of depression in Type 2 Diabetes Mellitus (DM) patients – The DEPDIAB study
2021 · Sujoy Majumdar, Binayak Sinha, et al. · Diabetes Research and Clinical Practice · 26
Management of diabetes in patients with COVID-19
2020 · Jagat J Mukherjee, Kalyan K Gangopadhyay, et al. · The Lancet Diabetes & Endocrinology · 10
PDF
Testosterone replacement therapy in men with type 2 diabetes mellitus and functional hypogonadism –an Integrated Diabetes and Endocrine Academy (IDEA) consensus guideline
2021 · Sujoy Majumdar, Jagat Jyoti Mukherjee, et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 8
Consensus on "Basal insulin in the management of Type 2 Diabetes: Which, When and How?"
2017 · Samit Ghosal, Binayak Sinha, et al. · PubMed · 4
An overview of therapeutic options of obesity management in India: the Integrated Diabetes and Endocrinology Academy (IDEA) 2023 Congress update
2024 · Subir Ray, Nitin Kapoor, et al. · Expert Review of Clinical Pharmacology · 3
Combination therapy with multiple oral hypoglycaemic agents together with short‐term basal insulin in new‐onset Type 2 diabetes mellitus with marked hyperglycaemia
2017 · S. Ray, J. J. Mukherjee · Diabetic Medicine · 1
Screening for Hepatic Steatosis and Fibrosis Among Physicians Attending the Integrated Diabetes and Endocrine Academy Conference: A Cross-Sectional Study
2026 · Binayak Sinha, Samit Ghosal, et al. · Cureus
Wcn25-3303 Reassuring Usage of Sglt-2i and Raasb in Indian Patients With Type 2 Diabetes and Ckd: a Nationwide Cross Selection Study (cite 1)
2025 · Samit Ghosal, Binayak Sinha, et al. · Kidney International Reports
PDF
Comparing the Efficacy and Tolerability of Oral Semaglutide and Weekly Injectable Dulaglutide: A Real-World Indian Experience
2024 · Binayak Sinha, Samit Ghosal, et al. · Journal of Diabetes and Treatment
Works count: 13
Citation count: 196
H-index: 6
I10-index: 5
Year
Topic
Type